Get started
Author

Kristina Fritsch

Observed names: Fritsch, K., Fritsch, Kristina, K Fritsch, K. Fritsch
Institution: Kantonsspital Baden
OpenAlex ID: A5069423665
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis
2015 · B. Kasenda, A.J.M. Ferreri, et al. · Annals of Oncology · 191
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
2016 · K Fritsch, B Kasenda, et al. · Leukemia · 183
PDF
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
2016 · Gerald Illerhaus, Benjamin Kasenda, et al. · The Lancet Haematology · 174
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
2011 · K. Fritsch, B. Kasenda, et al. · Annals of Oncology · 126
PDF
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study
2012 · B. Kasenda, E. Schorb, et al. · Annals of Oncology · 107
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
2013 · E. Schorb, B. Kasenda, et al. · Haematologica · 95
PDF
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group
2017 · B Kasenda, G Ihorst, et al. · Leukemia · 93
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
2016 · Elisabeth Schorb, Juergen Finke, et al. · BMC Cancer · 72
PDF
Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation - an International Primary Central Nervous System Lymphoma Study Group project
2012 · J. E. Bromberg, J. K. Doorduijn, et al. · Haematologica · 71
PDF
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
2017 · E Schorb, C P Fox, et al. · Bone Marrow Transplantation · 69
PDF
18F-FDG PET Is an Independent Outcome Predictor in Primary Central Nervous System Lymphoma
2012 · Benjamin Kasenda, Vanessa Haug, et al. · Journal of Nuclear Medicine · 44
PDF
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study
2015 · B. Kasenda, E. Schorb, et al. · Annals of Oncology · 28
Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT
2015 · A O'Neill, K Mikesch, et al. · Bone Marrow Transplantation · 24
Suppression of granzyme B activity and caspase-3 activation in leukaemia cells constitutively expressing the protease inhibitor 9
2013 · Kristina Fritsch, Jürgen Finke, et al. · Annals of Hematology · 24
Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg
2012 · Gerald Illerhaus, Kristina Fritsch, et al. · Blood · 22
The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis
2018 · Tilman Hottenrott, Elisabeth Schorb, et al. · Journal of Neurology · 21
Primary CNS Lymphoma—Radiation-Free Salvage Therapy by Second Autologous Stem Cell Transplantation
2010 · Benjamin Kasenda, Elisabeth Schorb, et al. · Transplantation and Cellular Therapy · 18
PDF
The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients
2012 · Benjamin Kasenda, Marcel Rehberg, et al. · Annals of Hematology · 14
Favourable outcomes of poor prognosis diffuse large B‐cell lymphoma patients treated with dose‐dense Rituximab, high‐dose Methotrexate and six cycles of CHOP ‐14 compared to first‐line autologous transplantation
2017 · Tim Strüßmann, Kristina Fritsch, et al. · British Journal of Haematology · 9
First-Line Treatment and Outcome of Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL) – A Systematic Review and Individual Patient Data Meta-Analysis
2012 · Benjamin Kasenda, Andrés J.M. Ferreri, et al. · Blood · 9
Quality of Life in Patients with Primary CNS Lymphoma - a Pooled Analysis from Three Prospective Multicentre Trials
2016 · Benjamin Kasenda, Gabriele Ihorst, et al. · Blood · 2
Constitutive Expression of the Granzyme B Inhibitor PI-9 Protects Leukemic Cells from Granzyme B Induced Apoptosis.
2005 · Carsten Grullich, Kristina Fritsch, et al. · Blood · 2
Elimination of Established Risk-Factors in Primary Central Nervous System Lymphoma - Impact of High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantaion - a Multicenter Retrospective Analysis
2011 · Elisabeth Schorb, Benjamin Kasenda, et al. · Blood · 1
Agile Learning With eduScrum
2026 · Willy Wijnands, Kristina Fritsch · IGI Global eBooks
Primäres Lymphom des Zentralnervensystems (PZNSL)
2026 · Schweizerische Gesellschaft für Hämatologie, Grosu, Anca-Ligia, et al. · PUBLISSO (German National Library of Medicine)
Works count: 39
Citation count: 1,399
H-index: 17
I10-index: 18
Year
Topic
Type